Development of electrochemical methods to enzymatically detect lactate and glucose using imaginary impedance for enhanced management of glycemic compromised patients

Blake Morrow, Aldin Malkoc, Tiffany Gong, David Probst, Chi Lin, Ayan Sen, Jeffrey LaBelle

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Lactate is an important biological marker that can provide valuable information for patients who have experienced a traumatic injury. Additionally, when coupled with glucose, the severity and likely prognosis of a traumatic injury can be determined. Because monitoring various markers proves useful in diagnosis and treatment of trauma patients, monitoring both glucose and lactate simultaneously may be especially useful for diabetic patients who have suffered a traumatic injury. Previously, using electrochemical impedance spectroscopy (EIS), a sensor capable of measuring two affinity-based biomarkers simultaneously was demonstrated using the biomarker’s specific optimal frequency to develop a deconvolution algorithm, which allowed for the measurement of two biomarkers from a single signal. Herein, while developing an EIS lactate sensor, dual enzymatic biomarker detection of lactate and glucose via EIS was also attempted. Both biomarkers were validated individually with the lactate sensor being additionally validated on whole blood samples. The EIS lactate biosensor achieved a range of detection from 0 to 32 mM of lactate and the glucose sensor a range of 0–100 mg/dL of glucose, which are representative of the likely physiological ranges that trauma patients experience. However, the preliminary attempt of dual marker detection was unsuccessful due to suspected accumulation of reduced redox probe on the surface of the self-assembled monolayer (SAM). Individually, the optimal frequency of lactate was determined to be 69.75 Hz and that of glucose was determined to be 31.5 Hz. However, when combined onto one sensor, no discernable optimal frequency could be determined which again was suspected to be due to the accumulation of the reduced redox probe at the surface of the SAM.

Original languageEnglish (US)
Pages (from-to)179-191
Number of pages13
JournalCritical Reviews in Biomedical Engineering
Volume47
Issue number3
DOIs
StatePublished - Jan 1 2019
Externally publishedYes

Fingerprint

Biomarkers
Glucose
Electrochemical impedance spectroscopy
Sensors
Self assembled monolayers
Glucose sensors
Patient monitoring
Deconvolution
Biosensors
Blood
Monitoring
Oxidation-Reduction

Keywords

  • Electrochemical impedance spectroscopy
  • Glycemic control
  • Gold disk electrode
  • Imaginary impedance
  • Lactate
  • Lower limit of detection
  • Point-of-care
  • Quality control
  • Type 1 diabetes
  • Type 2 diabetes

ASJC Scopus subject areas

  • Biomedical Engineering

Cite this

Development of electrochemical methods to enzymatically detect lactate and glucose using imaginary impedance for enhanced management of glycemic compromised patients. / Morrow, Blake; Malkoc, Aldin; Gong, Tiffany; Probst, David; Lin, Chi; Sen, Ayan; LaBelle, Jeffrey.

In: Critical Reviews in Biomedical Engineering, Vol. 47, No. 3, 01.01.2019, p. 179-191.

Research output: Contribution to journalArticle

Morrow, Blake ; Malkoc, Aldin ; Gong, Tiffany ; Probst, David ; Lin, Chi ; Sen, Ayan ; LaBelle, Jeffrey. / Development of electrochemical methods to enzymatically detect lactate and glucose using imaginary impedance for enhanced management of glycemic compromised patients. In: Critical Reviews in Biomedical Engineering. 2019 ; Vol. 47, No. 3. pp. 179-191.
@article{d201062090cf40319bed74ce24020904,
title = "Development of electrochemical methods to enzymatically detect lactate and glucose using imaginary impedance for enhanced management of glycemic compromised patients",
abstract = "Lactate is an important biological marker that can provide valuable information for patients who have experienced a traumatic injury. Additionally, when coupled with glucose, the severity and likely prognosis of a traumatic injury can be determined. Because monitoring various markers proves useful in diagnosis and treatment of trauma patients, monitoring both glucose and lactate simultaneously may be especially useful for diabetic patients who have suffered a traumatic injury. Previously, using electrochemical impedance spectroscopy (EIS), a sensor capable of measuring two affinity-based biomarkers simultaneously was demonstrated using the biomarker’s specific optimal frequency to develop a deconvolution algorithm, which allowed for the measurement of two biomarkers from a single signal. Herein, while developing an EIS lactate sensor, dual enzymatic biomarker detection of lactate and glucose via EIS was also attempted. Both biomarkers were validated individually with the lactate sensor being additionally validated on whole blood samples. The EIS lactate biosensor achieved a range of detection from 0 to 32 mM of lactate and the glucose sensor a range of 0–100 mg/dL of glucose, which are representative of the likely physiological ranges that trauma patients experience. However, the preliminary attempt of dual marker detection was unsuccessful due to suspected accumulation of reduced redox probe on the surface of the self-assembled monolayer (SAM). Individually, the optimal frequency of lactate was determined to be 69.75 Hz and that of glucose was determined to be 31.5 Hz. However, when combined onto one sensor, no discernable optimal frequency could be determined which again was suspected to be due to the accumulation of the reduced redox probe at the surface of the SAM.",
keywords = "Electrochemical impedance spectroscopy, Glycemic control, Gold disk electrode, Imaginary impedance, Lactate, Lower limit of detection, Point-of-care, Quality control, Type 1 diabetes, Type 2 diabetes",
author = "Blake Morrow and Aldin Malkoc and Tiffany Gong and David Probst and Chi Lin and Ayan Sen and Jeffrey LaBelle",
year = "2019",
month = "1",
day = "1",
doi = "10.1615/CritRevBiomedEng.2019026533",
language = "English (US)",
volume = "47",
pages = "179--191",
journal = "Critical Reviews in Biomedical Engineering",
issn = "0278-940X",
publisher = "Begell House Inc.",
number = "3",

}

TY - JOUR

T1 - Development of electrochemical methods to enzymatically detect lactate and glucose using imaginary impedance for enhanced management of glycemic compromised patients

AU - Morrow, Blake

AU - Malkoc, Aldin

AU - Gong, Tiffany

AU - Probst, David

AU - Lin, Chi

AU - Sen, Ayan

AU - LaBelle, Jeffrey

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Lactate is an important biological marker that can provide valuable information for patients who have experienced a traumatic injury. Additionally, when coupled with glucose, the severity and likely prognosis of a traumatic injury can be determined. Because monitoring various markers proves useful in diagnosis and treatment of trauma patients, monitoring both glucose and lactate simultaneously may be especially useful for diabetic patients who have suffered a traumatic injury. Previously, using electrochemical impedance spectroscopy (EIS), a sensor capable of measuring two affinity-based biomarkers simultaneously was demonstrated using the biomarker’s specific optimal frequency to develop a deconvolution algorithm, which allowed for the measurement of two biomarkers from a single signal. Herein, while developing an EIS lactate sensor, dual enzymatic biomarker detection of lactate and glucose via EIS was also attempted. Both biomarkers were validated individually with the lactate sensor being additionally validated on whole blood samples. The EIS lactate biosensor achieved a range of detection from 0 to 32 mM of lactate and the glucose sensor a range of 0–100 mg/dL of glucose, which are representative of the likely physiological ranges that trauma patients experience. However, the preliminary attempt of dual marker detection was unsuccessful due to suspected accumulation of reduced redox probe on the surface of the self-assembled monolayer (SAM). Individually, the optimal frequency of lactate was determined to be 69.75 Hz and that of glucose was determined to be 31.5 Hz. However, when combined onto one sensor, no discernable optimal frequency could be determined which again was suspected to be due to the accumulation of the reduced redox probe at the surface of the SAM.

AB - Lactate is an important biological marker that can provide valuable information for patients who have experienced a traumatic injury. Additionally, when coupled with glucose, the severity and likely prognosis of a traumatic injury can be determined. Because monitoring various markers proves useful in diagnosis and treatment of trauma patients, monitoring both glucose and lactate simultaneously may be especially useful for diabetic patients who have suffered a traumatic injury. Previously, using electrochemical impedance spectroscopy (EIS), a sensor capable of measuring two affinity-based biomarkers simultaneously was demonstrated using the biomarker’s specific optimal frequency to develop a deconvolution algorithm, which allowed for the measurement of two biomarkers from a single signal. Herein, while developing an EIS lactate sensor, dual enzymatic biomarker detection of lactate and glucose via EIS was also attempted. Both biomarkers were validated individually with the lactate sensor being additionally validated on whole blood samples. The EIS lactate biosensor achieved a range of detection from 0 to 32 mM of lactate and the glucose sensor a range of 0–100 mg/dL of glucose, which are representative of the likely physiological ranges that trauma patients experience. However, the preliminary attempt of dual marker detection was unsuccessful due to suspected accumulation of reduced redox probe on the surface of the self-assembled monolayer (SAM). Individually, the optimal frequency of lactate was determined to be 69.75 Hz and that of glucose was determined to be 31.5 Hz. However, when combined onto one sensor, no discernable optimal frequency could be determined which again was suspected to be due to the accumulation of the reduced redox probe at the surface of the SAM.

KW - Electrochemical impedance spectroscopy

KW - Glycemic control

KW - Gold disk electrode

KW - Imaginary impedance

KW - Lactate

KW - Lower limit of detection

KW - Point-of-care

KW - Quality control

KW - Type 1 diabetes

KW - Type 2 diabetes

UR - http://www.scopus.com/inward/record.url?scp=85068012645&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85068012645&partnerID=8YFLogxK

U2 - 10.1615/CritRevBiomedEng.2019026533

DO - 10.1615/CritRevBiomedEng.2019026533

M3 - Article

VL - 47

SP - 179

EP - 191

JO - Critical Reviews in Biomedical Engineering

JF - Critical Reviews in Biomedical Engineering

SN - 0278-940X

IS - 3

ER -